Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D07TXJ
|
||||
Former ID |
DCL000772
|
||||
Drug Name |
Dextofisopam
|
||||
Synonyms |
R-Tofisopam; Dextofisopam (USAN/INN); (5R)-1-(3,4-dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl-5H-2,3-benzodiazepine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Irritable bowel syndrome [ICD9: 564.1, 787.91; ICD10:A09, K58, K59.1] | Phase 2 | [536224] | ||
Company |
Vela Pharmaceuticals
|
||||
Structure |
Download2D MOL |
||||
Formula |
C22H26N2O4
|
||||
Canonical SMILES |
CCC1C(=NN=C(C2=CC(=C(C=C12)OC)OC)C3=CC(=C(C=C3)OC)OC)C
|
||||
InChI |
1S/C22H26N2O4/c1-7-15-13(2)23-24-22(14-8-9-18(25-3)19(10-14)26-4)17-12-21(28-6)20(27-5)11-16(15)17/h8-12,15H,7H2,1-6H3/t15-/m0/s1
|
||||
InChIKey |
RUJBDQSFYCKFAA-HNNXBMFYSA-N
|
||||
CAS Number |
CAS 82059-50-5
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
SuperDrug ATC ID |
A10BG03
|
||||
SuperDrug CAS ID |
cas=111025468
|
||||
Target and Pathway | |||||
Target(s) | Peripheral-type benzodiazepine receptor | Target Info | Agonist | [536224] | |
Gamma-aminobutyric acid receptor | Target Info | Agonist | [536224] | ||
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
HTLV-I infection | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.